热门资讯> 正文
SMR, MESO and SMMT are among pre market gainers
2024-03-28 20:41
- Gainers: Avalo Therapeutics (AVTX) +324% stock more than triples on Anti-IL-1β mAb acquisition.
- Binah Capital Group (BCG) +100%.
- Kidpik (PIK) +72%.
- Cazoo Group (CZOO) +44%.
- iBio (IBIO) +30%.
- Andretti Acquisition (WNNR) +23%.
- Atlas Lithium Corporation (ATLX) +18% FORM 10-K | Annual Report
- Allego NV (ALLG) +18%.
- Akebia Therapeutics (AKBA) +17% stock jumps as FDA clears renal anemia therapy
- Millennium Group International (MGIH) +17%.
- Sprinklr (CXM) +12% Q4 earnings call release
- Erasca (ERAS) +15% to get $45M funding via private placement.
- GigaCloud Technology (GCT) +10% FORM 10-K | Annual Report
- China Automotive Systems (CAAS) +10% Q4 earnings call release
- Syra Health (SYRA) +13% gets healthcare workforce contract in Missouri
- RH (RH) +9%.
- Marpai (MRAI) +8% Q4 earnings call release
- Mesoblast (MESO) +8%.
- Energous (WATT) +8% FY earnings call release
- BYND Cannasoft Enterprises (BCAN) +6%.
- Summit Therapeutics (SMMT) +7%.
- Spectral (MDAI) +6% Q4 earnings call release
- Solowin Holdings (SWIN) +5%.
- Brainsway (BWAY) +5% Announces Positive Results in Late-Life Depression Post-Marketing Analysis.
- NuScale Power Corporation (SMR) +1%.
More on premarket gainers & stock
- NuScale Power Corporation (SMR) Q3 2023 Earnings Call Transcript
- NuScale Power Corporation 2023 Q4 - Results - Earnings Call Presentation
- Mesoblast Limited (MESO) Q2 2024 Earnings Call Transcript
- Mesoblast gains as FDA backs regulatory plans for cell therapy
- NuScale plunges as Wells Fargo cuts to Sell equivalent on 'misguided' enthusiasm
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
